Homepage - Full Width Slider

Immunotherapy
- the future of cancer therapy

.

Error message

  • Warning: array_merge() [function.array-merge]: Argument #1 is not an array in pe_slider_block_view() (line 552 of /home/4/t/targovax/www/sites/all/modules/bigwig_tools/pe_slider/pe_slider.module).
  • Warning: array_merge() [function.array-merge]: Argument #1 is not an array in pe_slider_block_view() (line 552 of /home/4/t/targovax/www/sites/all/modules/bigwig_tools/pe_slider/pe_slider.module).

Primary endpoint reached

TRVX: Targovax AS has reached primary endpoint for the ongoing phase I/II clinical trial CT TG01-01
Read more

Gunnar Gårdemyr new CEO

The board of Targovax is pleased to announce Mr. Gunnar Gårdemyr as the new CEO of the company from January 12th, 2015.
Read more

New member of the board

Harald Arnet, CEO in Datum AS, was elected to be member of Targovax’s Board of Directors.
Read more